The impact of a high-risk disease management program on perinatal outcomes in a managed care organization.
Improvements in technology have increased the chances of survival for the micropremature infant and the very low birth-weight infant but have significantly increased the financial burden of health care organizations. This economic burden has a significant impact on third-party payers and on society in general. Of the annual US 10.2 billion dollars spent on newborn care alone, 57% is disproportionately consumed by the 10% of infants who are born preterm.
Hawkins
Michelle R
MR
Johns Hopkins HealthCare, LLC, USA.
D019090:Case Management / Q000458:organization & administration*; D017281:Cost of Illness; D019468:Disease Management; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D007902:Length of Stay / Q000706:statistics & numerical data; D008329:Managed Care Programs / Q000458:organization & administration*; D008484:Medicaid / Q000458:organization & administration; D007752:Obstetric Labor, Premature / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D017063:Outcome Assessment, Health Care; D010500:Perinatology / Q000458:organization & administration*; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D015397:Program Evaluation; D012189:Retrospective Studies; D018570:Risk Assessment; D014481:United States / Q000453:epidemiology